Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 6 - Number 3

Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy

, 6(3): 223 - 237

Guido Frumento, Tiziana Piazza, Emma Di Carlo and Silvano Ferrini


DOI: 10.2174/187153006778250019




Drug Therapy Aimed at Adenylyl Cyclase to Regulate Cyclic Nucleotide Signaling

, 6(3): 239 - 247

Kousaku Iwatsubo, Satoshi Okumura and Yoshihiro Ishikawa


DOI: 10.2174/187153006778249994




Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia

, 6(3): 249 - 258

Beatriz R. Olson


DOI: 10.2174/187153006778249985




Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?

, 6(3): 259 - 269

Udo Oppermann


DOI: 10.2174/187153006778250000




Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma

, 6(3): 271 - 277

Girolamo Ranieri, Eustachio Ruggieri, Gaetano Falco, Nicola Zizzo, Eliseo Mattioli, Alfredo Francesco Zito, Rosa Patruno and Giampietro Gasparini


DOI: 10.2174/187153006778250028




Antioxidant Effects of Glutathione and IGF in a Hyperglycaemic Cell Culture Model of Fibroblasts: Some Actions of Advanced Glycaemic end Products (AGE) and Nicotine

, 6(3): 279 - 286

Z. A. Rahman and M. Soory


DOI: 10.2174/187153006778250037




Origin and Biological Significance of Shed-Membrane Microparticles

, 6(3): 287 - 294

A. Tesse, M. C. Martinez, F. Meziani, B. Hugel, M. A. Panaro, V. Mitolo, J.-M. Freyssinet and R. Andriantsitohaina


DOI: 10.2174/187153006778249976




Anthracyclines-Contra Cruciform Extrusion in DNA Regulating Sequences

, 6(3): 295 - 302

Viktor Viglasky


DOI: 10.2174/187153006778250046




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science